So far the startup has raised over $75 million to research treatments for age related decline, and has brought together some of the world’s leading scientists and researchers in hopes to increase lifespan and reduce disease for everyone, even companion animals. Life Biosciences was cofounded in 2017 by David Sinclair a Harvard geneticist, Tristan Edwards a former hedge fund manager, and it was backed by Adam Neumann of WeWork.
It speaks volumes that a young startup such as Life Biosciences has been able to attract Fortune 500 talent, and it speaks to the promise and maturity of the longevity industry. In present day one can find multi-day conventions entirely dedicated to curing aging and increasing health and lifespans. Various startups such as Calico and Unity Biotechnology are hoping to capitalize on the quest for the fountain of youth in the aging population.
Life Extension Foundation founder Bill Faloon recent said, “What we’re looking at is evidence that for the first time in human history, there’s a population-wide delayed effect of aging.”
While we may still be a ways off from cracking the code to immortality, there has been much progress. The average life expectancy was a mere 35 years in 1776, this grew to 47.3 by 1900, and jumped to 77 in 2000 according to the National Center for Health Statistics.
Modern day has an aging society that has no storage of older citizens looking to extend their time on the planet, while improving the quality of their lives during the golden years. Several studies have confirmed that the number of Americans aged 65+ has increased ten-fold in the last century with the elderly also living substantially longer. Compared to 40 years ago fewer elderly die from major disease according to the CDC, creating a huge target market looking eagerly to the anti-aging and longevity industry to live healthier for longer.
